Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

iShares Nasdaq Biotechnology ETF (IBB)

During the Trading Day
346.23 +12.89 / +3.87%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
346.23 0.00 / 0.00%
 
Volume: 80.8K

Investment Objective

The investment seeks to track the investment results of the NASDAQ Biotechnology Index, which contains securities of NASDAQ  listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals and that also meet other eligibility criteria determined by NASDAQ OMX. The fund generally invests at least 90% of its assets in securities of the index and in depositary receipts representing securities of the index. It may invest the remainder of its assets in certain futures, options and swap contracts, cash and cash equivalents, as well as in securities not included in the index. It is non-diversified.

Performance

1 month-12.83% 3 years+34.97%
3 months-8.63% 5 years+33.10%
1 year+20.54% Since inception+8.76%
Data through 09/02/2015

Quote Details

Previous close$333.34
Open day’s range333.44 – 346.23
Net asset value (NAV)333.25 (09/01/2015)
Daily volume1,705,625
Average volume (3 months)1,865,488
Data as of 3:59pm ET, 09/02/2015

Peer Comparisonvs. Health ETFs

 IBBCategory
Performance 5-yr return+33.10%+26.72%
Expense Gross exp ratio0.48%0.46%
Risk 5 year sharpe ratio1.921.76
Net assets$10.0B$2.2B
Average market cap$21.9B$38.7B
Average P/E28.526.0
Dividend / Share--0.21%

Competitors

XLV Health Care Select Sector SPDR® Fund
VHT Vanguard Health Care Index Fund ETF Shar...
RYH Guggenheim S&P 500® Equal Weight Health...

Holdings

Top 5 Sectors
Portfolio weighting
Healthcare 99.91%
Business service 0.09%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
CELG Celgene8.66%
AMGN Amgen8.53%
GILD Gilead Sciences7.92%
REGN Regeneron Pharmaceuticals7.34%
BIIB Biogen6.06%
ALXN Alexion Pharmaceuticals Inc5.14%
ILMN Illumina Inc4.02%
VRTX Vertex Pharmaceuticals Inc3.97%
BMRN Biomarin Pharmaceutical Inc3.21%
MYL Mylan NV2.91%

Partner Offers